Literature DB >> 9440483

Plasma total homocysteine levels in hyperthyroid and hypothyroid patients.

B G Nedrebø1, U B Ericsson, O Nygård, H Refsum, P M Ueland, A Aakvaag, S Aanderud, E A Lien.   

Abstract

We found a higher plasma concentration of total homocysteine (tHcy), an independent risk factor for cardiovascular disease, in patients with hypothyroidism (mean, 16.3 micromol/L; 95% confidence interval [CI], 14.7 to 17.9 micromol/L) than in healthy controls (mean, 10.5 micromol/L; 95% CI, 10.1 to 10.9 micromol/L). The tHcy level of hyperthyroid patients did not differ significantly from that of the controls. Serum creatinine was higher in hypothyroid patients and lower in hyperthyroid patients than in controls, whereas serum folate was higher in hyperthyroid patients compared with the two other groups. In multivariate analysis, these differences did not explain the higher tHcy concentration in hypothyroidism. We confirmed the observation of elevated serum cholesterol in hypothyroidism, which together with the hyperhomocysteinemia may contribute to an accelerated atherogenesis in these patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9440483     DOI: 10.1016/s0026-0495(98)90198-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

1.  Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism.

Authors:  Nedret Tanaci; Derun Taner Ertugrul; Mustafa Sahin; Muammer Yucel; Irem Olcay; Nilgun Guvener Demirag; Alptekin Gursoy
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

2.  The effects of hormones of the hypothalamo-hypophyseal-adrenal, renin-angiotensin, and thyroid hormone systems on the formation of dyscirculatory encephalopathy.

Authors:  V I Skvortsova; I A Platonova; T V Tvorogova; O V Volkovenko; L I Demidova; I V Ostrovtsev
Journal:  Neurosci Behav Physiol       Date:  2004-11

Review 3.  Risk factors for cardiovascular disease in subclinical hypothyroidism.

Authors:  F Decandia
Journal:  Ir J Med Sci       Date:  2017-05-10       Impact factor: 1.568

Review 4.  Homocysteine and coronary risk.

Authors:  N Seshadri; K Robinson
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

Review 5.  Hyperhomocysteinemia and thrombosis.

Authors:  M Cattaneo
Journal:  Lipids       Date:  2001       Impact factor: 1.880

Review 6.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 7.  The association of homocysteine and coronary artery disease.

Authors:  Gregory M Gauthier; Jon G Keevil; Patrick E McBride
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

Review 8.  Novel markers of peripheral arterial disease.

Authors:  Farhan J Khawaja; Iftikhar J Kullo
Journal:  Vasc Med       Date:  2009-11       Impact factor: 3.239

9.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18

10.  Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status.

Authors:  Henri Blehaut; Clotilde Mircher; Aimé Ravel; Martine Conte; Veronique de Portzamparc; Gwendael Poret; Françoise Huon de Kermadec; Marie-Odile Rethore; Franck G Sturtz
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.